Search

Your selection

None

Filter by content type

Filter by content year

Event

Vaxart, Inc. Full Year 2025 Business Update and Financial Results Conference Call

Thu, 03/12/2026 - 16:30 - … Update and Financial Results Conference Call Event Type Earnings Conference Call Listen to Webcast March 12, … Update and Financial Results Conference Call Event Type Earnings Conference Call Listen to Webcast March 12, …
Event

Vaxart, Inc. Stockholder Fireside Chat

Fri, 03/13/2026 - 16:30 - … Fireside Chat Vaxart, Inc. Stockholder Fireside Chat Event Type Conference Presentation Listen to Webcast March 13, 2026 … Fireside Chat Vaxart, Inc. Stockholder Fireside Chat Event Type Conference Presentation Listen to Webcast March 13, 2026 …
Event

Oppenheimer 36th Annual Healthcare Life Sciences Conference

Wed, 02/25/2026 - 16:00 - … 36th Annual Healthcare Life Sciences Conference Event Type Conference Presentation Listen to Webcast February 25, … 36th Annual Healthcare Life Sciences Conference Event Type Conference Presentation Listen to Webcast February 25, …
Event

Vaxart to Participate in the Global BioInnovation

Tue, 01/13/2026 - 14:30 - … Vaxart to Participate in the Global BioInnovation Event Type Conference Presentation Listen to Webcast January 13, … Vaxart to Participate in the Global BioInnovation Event Type Conference Presentation Listen to Webcast January 13, …
Event

Vaxart, Inc. Stockholder Fireside Chat

Tue, 11/18/2025 - 16:30 - … Fireside Chat Vaxart, Inc. Stockholder Fireside Chat Event Type Conference Presentation Listen to Webcast November 18, … Fireside Chat Vaxart, Inc. Stockholder Fireside Chat Event Type Conference Presentation Listen to Webcast November 18, …
Event

Vaxart, Inc. Third Quarter 2025 Business Update and Financial Results Conference Call

Thu, 11/13/2025 - 16:30 - … Update and Financial Results Conference Call Event Type Earnings Conference Call Listen to Webcast November 13, … Update and Financial Results Conference Call Event Type Earnings Conference Call Listen to Webcast November 13, …
News

Vaxart Publishes Positive, Complete Data from a Phase 2b Challenge Study of its First-Generation Oral Pill Norovirus Vaccine Candidate in Science Translational Medicine

May 14, 2025 - … and vaccination in older people. Maturitas   82 , 50-55 (2015). About Vaxart  Vaxart is a clinical-stage biotechnology … and vaccination in older people. Maturitas   82 , 50-55 (2015). About Vaxart  Vaxart is a clinical-stage biotechnology … and vaccination in older people. Maturitas   82 , 50-55 (2015). About Vaxart  Vaxart is a clinical-stage biotechnology …
News

Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults

March 5, 2025 - … and vaccination in older people. Maturitas   82 , 50-55 (2015). 3. A. J. Hall , R. I. Glass , U. D. Parashar , New … and vaccination in older people. Maturitas   82 , 50-55 (2015). 3. A. J. Hall , R. I. Glass , U. D. Parashar , New … and vaccination in older people. Maturitas   82 , 50-55 (2015). 3. A. J. Hall , R. I. Glass , U. D. Parashar , New …

SEC Filings

… All 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 … All 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 …
News

Vaxart, Inc. Appoints Steven Lo as President, Chief Executive Officer, and Director

March 6, 2024 - … a clinical-stage biopharmaceutical company. From 2015 to 2019, he was the Chief Commercial Officer at Puma … a clinical-stage biopharmaceutical company. From 2015 to 2019, he was the Chief Commercial Officer at Puma … a clinical-stage biopharmaceutical company. From 2015 to 2019, he was the Chief Commercial Officer at Puma …
Scroll to Top